Lutris Pharma
Lutris Pharma is a biotechnology company focused on developing novel therapies for rare genetic diseases.
About
Lutris Pharma is a clinical-stage biotechnology company dedicated to developing transformative therapies for patients with rare genetic diseases. The company leverages its proprietary platform to identify and advance novel drug candidates with the potential to address significant unmet medical needs. Teams look it up for Biotech, MedTech, HealthTech.
Frequently asked
What does Lutris Pharma do?
Lutris Pharma is a Biotech company that offers Biotech. Teams look it up for MedTech, HealthTech, Drug Discovery. It is based in San Diego, United States and was founded in 2017. Public records show $170M in total funding. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has Lutris Pharma raised?
Lutris Pharma has raised a total of $170M in funding. The most recent round on record is Series A.
Where is Lutris Pharma headquartered?
Lutris Pharma is headquartered in San Diego, United States.
When was Lutris Pharma founded?
Lutris Pharma was founded in 2017.
What industry does Lutris Pharma operate in?
Lutris Pharma operates in Biotech, MedTech, HealthTech, Drug Discovery, Clinical Trials.
What is Lutris Pharma's current status?
Lutris Pharma's current operating status is: Inactive.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.